Processing your request


please wait...

 | Investigations Dataset

Stanford Foreign Corrupt Practices Act Clearinghouse a Collaboration with Sullivan & Cromwell LLP

Investigations Dataset

 
Investigation into Pfizer's Activities in Multiple Countries · Pfizer, Inc.

Information & Summary

Investigation into Pfizer's Activities in Multiple Countries

Related FCPA Matter:   Pfizer/Wyeth's Involvement in Multiple Countries between 1997 and 2007 Information

Information & Summary

Investigation Name:    Investigation into Pfizer's Activities in Multiple Countries

Trend:    None

Type of investigation:    Internal, SEC, DOJ

Other Agencies Investigating/Assisting with SEC/DOJ Investigation:   

  • Italian Public Attorney’s Office

Whistleblower:    Unknown

Summary

Pfizer Inc. (“Pfizer”) is a global pharmaceutical company that discovers, develops, manufactures and markets prescription medicines for humans and animals. Pfizer is incorporated in Delaware and is headquartered in New York. Its securities are registered with the Commission under Section 12(b) of the Exchange Act, and its common stock trades on the New York Stock Exchange under the symbol “PFE.”

In its November 5, 2004 10-Q report, Pfizer disclosed that it had voluntarily provided the Department of Justice and the Securities and Exchange Commission with information regarding an internal investigation that the company was conducting of certain potentially improper payments made in connection with foreign sales activities in Croatia. The company later expanded this disclosure to include foreign sales activities in "certain countries."

Pfizer resolved these matters with the SEC and the DOJ in August 2012.

Protected Content


Please Log In or Sign Up for a free account to access restricted features of the Clearinghouse website, including the Advanced Search form and the full case pages.

When you sign up, you will have the option to save your search queries performed on the Advanced Search form.